CTLs also secrete the CD271 ligand, named β-nerve growth factor (β-NGF), whose binding to its receptor, causes the down-regulation of the antigen expression on the melanoma cells’ surface that leads to the suppression of CTL activation (110). The gene discussed is NGFR; the disease is melanoma.